Reply concerning "Colchicine in coronary artery disease: Role of anti-inflammatory medications redefined": Prime time for anti-inflammatory agents for the management of cardiovascular diseases

被引：0
|
作者：
Akodad, Mariama [1 ,2 ]
Fauconnier, Jeremy [2 ]
Lacampagne, Alain [2 ]
Roubille, Francois [1 ,2 ]
机构：
[1] Univ Montpellier, PhyMedExp, CNRS, INSERM,UMR 9214,U1046, F-34295 Montpellier 5, France
[2] Univ Montpellier, Univ Hosp Montpellier, Cardiol Dept, F-34295 Montpellier 5, France
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2018年 / 254卷
关键词：
Inflammation; Cardiovascular diseases; Colchicine; Canakinumab;
D O I：
10.1016/j.ijcard.2017.12.059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [41] Pro/Anti-Inflammatory Cytokines in the Pathogenesis of Premature Coronary Artery Disease
    Khan, Dilshad Ahmed
    Ansari, Wafa Munir
    Khan, Farooq Ahmed
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011, 31 (07): : 561 - 567
  • [42] Lutein exerts anti-inflammatory effects in patients with coronary artery disease
    Chung, Rosanna W. S.
    Leanderson, Per
    Lundberg, Anna K.
    Jonasson, Lena
    ATHEROSCLEROSIS, 2017, 262 : 87 - 93
  • [43] Unmet needs in the management of atherosclerotic cardiovascular disease: Is there a role for emerging anti-inflammatory interventions?
    Lorenzatti, Alberto J.
    Retzlaff, Brenda M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 : 581 - 586
  • [44] Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease
    Ross, Steven J.
    Elgendy, Islam Y.
    Bavry, Anthony A.
    CURRENT CARDIOLOGY REPORTS, 2017, 19 (01)
  • [45] Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease
    Steven J. Ross
    Islam Y. Elgendy
    Anthony A. Bavry
    Current Cardiology Reports, 2017, 19
  • [46] Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents
    Hall, Christopher J.
    Wicker, Sophie M.
    Chien, An-Tzu
    Tromp, Alisha
    Lawrence, Lisa M.
    Sun, Xueying
    Krissansen, Geoffrey W.
    Crosier, Kathryn E.
    Crosier, Philip S.
    DISEASE MODELS & MECHANISMS, 2014, 7 (09) : 1069 - 1081
  • [47] ASSOCIATION BETWEEN CHRONIC INFLAMMATORY DISEASES, ANTI-INFLAMMATORY MEDICATIONS AND RISK OF PROSTATE CANCER
    Beckmann, Kerri
    Russell, Beth
    Josephs, Debra
    Garmo, Hans
    Haggstrom, Christel
    Holmberg, Lars
    Stattin, Par
    Van Hemelrijck, Mieke
    Adolfsson, Jan
    JOURNAL OF UROLOGY, 2019, 201 (04): : E596 - E597
  • [48] USE OF ANTI-INFLAMMATORY AGENTS IN DESTRUCTIVE CORNEAL DISEASE
    SMOLIN, G
    TRANSACTIONS OF THE OPHTHALMOLOGICAL SOCIETIES OF THE UNITED KINGDOM, 1978, 98 (SEP): : 406 - 409
  • [49] The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis
    Kottoor, Santhosh J.
    Arora, Rohit R.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 23 (06) : 483 - 493
  • [50] Anti-inflammatory agents in Alzheimer's disease.
    Aisen P.S.
    Current Neurology and Neuroscience Reports, 2002, 2 (5) : 405 - 409
12345